InsiderPulse
← 10-K / 10-Q
10-QBRGX

BIOREGENX, INC.

Filed 2026-05-20Period ending 2026-03-31
EDGAR ↗All periods →

Income Statement

Line Item2026-03-31Q/QY/Y
Revenue$426K-17.3%
Cost of Revenue$78K-28.6%
Gross Profit$348K-14.2%
SG&A Expense$396K-32.9%
Operating Income-$50K+74.2%
Interest Expense$77K+3.8%
Net Income-$26K+90.1%
EPS (Basic)$0.00
EPS (Diluted)$0.00

Balance Sheet

Line Item2026-03-31Q/QY/Y
Accounts Receivable$18K-53.7%+64.8%
Inventory$93K-13.2%-33.9%
Current Assets$190K-24.3%-35.3%
Total Assets$337K-18.0%-30.2%
Current Liabilities$4.0M-1.9%+5.4%
Total Liabilities$4.9M-1.6%+20.5%
Stockholders' Equity-$4.5M+0.1%-27.4%

Cash Flow

Line Item2026-03-31Q/QY/Y
Operating Cash Flow$27K-29.4%
Financing Cash Flow-$50K-382.1%